Palantir Stock Navigates Dual Challenges Amid Geopolitical and Contract Shifts

Palantir Technologies Inc. shares are facing a complex set of pressures, even after rallying 12 percent in the prior week. Initial investor enthusiasm driven by escalating Middle East tensions is showing signs of fading as the new week begins. Concurrently, the data analytics firm is tasked with restructuring its artificial intelligence systems for the Pentagon following the exclusion of Anthropic from government contracts.

Operational Strength Meets Valuation Debate

The company’s recent financial performance provides a solid foundation. Fourth-quarter revenue surged 70 percent to $1.41 billion. Its U.S. commercial business saw remarkable growth of 137 percent, while government revenue increased by 66 percent. Management has set an ambitious revenue target of $7.18 to $7.20 billion for the full year 2026.

Despite these strong figures, the stock’s valuation remains a central point of contention among analysts. Goldman Sachs reduced its price target from $188 to $182, maintaining a neutral rating. The firm argued that the current share price, trading at 243 times expected earnings, already reflects the company’s growth prospects. In contrast, UBS and Daiwa Securities both upgraded the stock to a buy rating following its 35 percent decline from recent highs, each setting a $180 price target. Rosenblatt Securities was more bullish, raising its target to $200 and citing growing demand for integrated defense solutions.

Geopolitical Tensions: A Mixed Catalyst

Recent U.S. military action initially provided a significant, if questionable, boost to the share price, sending it 15 percent higher against a generally weak market backdrop. Investors bet that the specialist software provider would benefit from potential increases in defense spending. Palantir holds a substantial $10 billion contract with the U.S. Army and supplies AI-powered targeting systems through the Project Maven program.

Whether Palantir’s technology is actively being used in recent operations remains unconfirmed. The company’s software is known to be utilized by the Israeli military, and its collaboration with the Pentagon is extensive. However, as noted by financial outlet Barron’s, the firm’s role in the current conflict is “not a foregone conclusion.” The broader defense sector came under pressure at the start of the week, and Palantir was no exception.

Should investors sell immediately? Or is it worth buying Palantir?

Pentagon Contract Shift Creates a New Hurdle

A separate, immediate challenge has emerged from a Pentagon decision. Anthropic’s AI models have been removed from government contracts after the two parties failed to reach an agreement on their use in autonomous weapons and domestic surveillance. This directly impacts Palantir, which, in partnership with Amazon Web Services, had integrated Anthropic’s Claude models for defense and intelligence agencies in November 2024. The company must now engineer these models out of its systems.

Market researchers at Piper Sandler identified Anthropic as a “pioneer” for deploying AI in sensitive government environments. They estimate that switching to alternative models will take time, even though Palantir’s platform is designed to be model-agnostic. The firm maintains its buy recommendation with a $230 price target. Other analysts point to “sufficient alternatives” and anticipate further large-scale contracts similar to the existing Army deal.

Outlook: A Test for the Premium Model

Palantir sits at the intersection of two powerful trends: widespread AI adoption and rising global defense expenditures. Nevertheless, its shares have declined more than five percent since the start of the year. Trading at approximately €135.40, the stock remains about 25 percent below its 52-week high.

The coming weeks will determine whether the geopolitical landscape provides enough support to offset concerns over its lofty valuation and the technical burden of replacing Anthropic’s AI. A critical factor will be the continued ability of its commercial business segment to exceed expectations through 2026.